Nobel Biocare implements new holding structure:
This article was originally published in Clinica
Executive Summary
Swedish dental implants company Nobel Biocare (Gothenburg) will set up a new Swiss holding structure, which, it says, will enhance its competitive position and give it access to wider capital markets. The new Swiss parent will be listed in Zurich and in Stockholm. The transaction will be effected via a share swap, with shareholders gaining one new share in Nobel Biocare AG for each existing share in Nobel Biocare AB. The latter will become a subsidiary of the new parent under the new structure. No changes in board composition are expected.